These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3085419)

  • 21. Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.
    Mortensen UM; Nielsen-Kudsk JE; Sondergaard HM; Jakobsen P; Jensen BS; Schmitz O; Nielsen TT
    Diabet Med; 2006 Mar; 23(3):327-30. PubMed ID: 16492219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of glibenclamide in oral insulin capsules.
    Singh BM; Wise PH; Marks V
    Lancet; 1991 Aug; 338(8762):308-70. PubMed ID: 1677127
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of two treatment models in type-II diabetic patients with poor metabolic control: Preformed combination of glibenclamide 2,5 mg + metformin 400 mg or mono-therapy with sulfonylurea at maximal doses? An evaluation at six months].
    D'Argenzio R; Cavallo P; Merante D; Morelli A
    Minerva Endocrinol; 1996 Sep; 21(3):101-10. PubMed ID: 9072666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
    Tan MH; Johns D; Strand J; Halse J; Madsbad S; Eriksson JW; Clausen J; Konkoy CS; Herz M;
    Diabet Med; 2004 Aug; 21(8):859-66. PubMed ID: 15270789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.
    Coppack SW; Lant AF; McIntosh CS; Rodgers AV
    Br J Clin Pharmacol; 1990 Jun; 29(6):673-84. PubMed ID: 2116159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
    Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ
    Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-insulin-dependent diabetics with secondary failure: insulin therapy at bedtime combined with glibenclamide].
    Maiz A; Arteaga A; Klaassen J; Velasco N; Borkosky M; Jiménez M; Acosta AM
    Rev Med Chil; 1993 Oct; 121(10):1135-41. PubMed ID: 8191117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
    Gudat U; Bungert S; Kemmer F; Heinemann L
    Diabet Med; 1998 Mar; 15(3):194-8. PubMed ID: 9545119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.
    Tuomi T; Honkanen EH; Isomaa B; Sarelin L; Groop LC
    Diabetes Care; 2006 Feb; 29(2):189-94. PubMed ID: 16443858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.
    Ylitalo P; Oksala H; Pitkäjärvi T
    Arzneimittelforschung; 1985; 35(10):1596-9. PubMed ID: 3935120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effect of glibenclamide upon red cell transglutaminase activity in diabetic patients.
    Coves MJ; Gomis R; Ribes JL; Arbos MA; Casamitjana R; Vilardell E
    J Endocrinol Invest; 1987 Dec; 10(6):565-8. PubMed ID: 2894389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the efficacy of metformin-glibenclamide treatment in overweight non-insulin dependent diabetics].
    Laurenti O; Bravi MC; Faldetta MC; De Mattia G
    Clin Ter; 1992 Mar; 140(3):259-63. PubMed ID: 1568370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
    Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
    Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-stenotic coronary blood flow at rest is not altered by therapeutic doses of the oral antidiabetic drug glibenclamide in patients with coronary artery disease.
    Reffelmann T; Klues HG; Hanrath P; Schwarz ER
    Heart; 2002 Jan; 87(1):54-60. PubMed ID: 11751665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glibenclamide induced prolonged hypoglycaemia.
    Sonnenblick M; Shilo S
    Age Ageing; 1986 May; 15(3):185-9. PubMed ID: 3090865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.
    Holstein A; Plaschke A; Hammer C; Egberts EH
    Eur J Clin Pharmacol; 2003 Jun; 59(2):91-7. PubMed ID: 12698302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.
    Mohan V; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1990 Aug; 38(8):537-41. PubMed ID: 2123183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamics.
    Rydberg T; Jönsson A; Karlsson MO; Melander A
    Br J Clin Pharmacol; 1997 Apr; 43(4):373-81. PubMed ID: 9146849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
    Matthews DR; Cull CA; Stratton IM; Holman RR; Turner RC
    Diabet Med; 1998 Apr; 15(4):297-303. PubMed ID: 9585394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of glibenclamide: heterogeneity in its absorption.
    Ikegami H; Shima K; Tanaka A; Tahara Y; Hirota M; Kumahara Y
    Med J Osaka Univ; 1985 Mar; 35(3-4):55-61. PubMed ID: 3934509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.